# Jungle Capital

> Jungle Capital is a VC fund in Melbourne backing Medical, Health Care and Artificial Intelligence. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Melbourne, Australia
- Total investments: 4
- Last investment: Aug 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/kings-of-the-jungle-kotj-
- X (Twitter): http://twitter.com/junglecapital
- Website: http://www.junglecapital.com.au/

Jungle capital is an early stage investment group.Jungle capital has a particular fondness for online businesses given their ability to be both time and cost efficient. Jungle capital has an active investment network aimed to assist emerging companies through both equity injections and mentoring. they aim to provide you with what youneed to grow.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 50% |
| Health Care | 2 | 50% |
| Artificial Intelligence | 2 | 50% |
| Big Data | 1 | 25% |
| Hospital | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Venture - Series Unknown | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 50% |
| United Kingdom | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Presagen | Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its decentralized data-centric AI platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare productsthat are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership.With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility.With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.See Presagen.com and LifeWhisperer.com for more information. | $2.2M | Seed | Aug 01, 2021 |  |
| Biosceptre | Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from a wide range of malignancies. | $9.6M | Venture - Series Unknown | Mar 09, 2021 |  |
| Presagen | Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its decentralized data-centric AI platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare productsthat are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership.With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility.With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.See Presagen.com and LifeWhisperer.com for more information. | $2.2M | Seed | Feb 26, 2019 |  |
| Life Whisperer | Life Whisperer uses artificial intelligence (AI) to assist clinicians identify viable embryos in IVF, and to ultimately improve outcomes for couples wanting to have children.An international clinical study involving 12 IVF centers across the USA, Australia, New Zealand and Malaysia has demonstrated that Life Whisperer’s AI performs 30% betterthan highly skilled embryologists when identifying viable embryos from medical images.Life Whisperer is delivered to clinics via a scalable web-based tool and can be easily accessed on-demand by any clinic globally. | $3M | Seed | Nov 06, 2018 |  |

4 of 4 investments shown.

## Co-investors
- [3Lines](https://shizune.co/investors/profile/3lines) — VC Fund, 2 deals together
- Department of State Development South Australia — VC Fund, 1 deal together
- [Morgan Stanley](https://shizune.co/investors/profile/morgan-stanley) — VC Fund, 1 deal together
- Norcliffe Capital — VC Fund, 1 deal together
- [SHIFT Invest](https://shizune.co/investors/profile/shift-invest) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Jungle Capital invest in?

Jungle Capital invests primarily in Medical, Health Care and Artificial Intelligence startups, most often at Seed and Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jungle Capital last invest?

The most recent investment recorded for Jungle Capital closed in Aug 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co